These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17039363)

  • 1. Use of ziprasidone in patients with fibromyalgia: a case series.
    Calandre EP; Hidalgo J; Rico-Villademoros F
    Rheumatol Int; 2007 Mar; 27(5):473-6. PubMed ID: 17039363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label study of quetiapine in the treatment of fibromyalgia.
    Hidalgo J; Rico-Villademoros F; Calandre EP
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):71-7. PubMed ID: 16889882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].
    Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G;
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Simpson GM; Glick ID; Weiden PJ; Romano SJ; Siu CO
    Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
    Suppes T; McElroy SL; Sheehan DV; Hidalgo RB; Cosgrove VE; Gwizdowski IS; Feldman NS
    J Clin Psychiatry; 2014 Jan; 75(1):77-84. PubMed ID: 24345758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Ratner Y; Gibel A; Yorkov V; Ritsner MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1401-9. PubMed ID: 17669574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ; Myers RR
    Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
    Zhao T; Park TW; Yang JC; Huang GB; Kim MG; Lee KH; Chung YC
    Int Clin Psychopharmacol; 2012 Jul; 27(4):184-90. PubMed ID: 22426471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label study of levopromazine (methotrimeprazine) as an add-on therapy in fibromyalgia management.
    Rico-Villademoros F; Hidalgo J; Morillas-Arques P; Vilchez JS; Delgado-Rodriguez A; Calandre EP
    Clin Exp Rheumatol; 2009; 27(5 Suppl 56):S16-20. PubMed ID: 20074434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Arnold LM; Hirsch I; Sanders P; Ellis A; Hughes B
    Arthritis Rheum; 2012 Jul; 64(7):2387-97. PubMed ID: 22275142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics in the treatment of fibromyalgia: a case series with olanzapine.
    Rico-Villademoros F; Hidalgo J; Dominguez I; García-Leiva JM; Calandre EP
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):161-4. PubMed ID: 15610961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of switching to ziprasidone in italian patients with acute exacerbation of schizophrenia: an open-label trial.
    Mencacci C;
    Pharmacopsychiatry; 2012 Sep; 45(6):236-40. PubMed ID: 22592506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of atypical antipsychotics for the treatment of fibromyalgia.
    Rico-Villademoros F; Calandre EP; Slim M
    Drugs Today (Barc); 2014 Jun; 50(6):435-44. PubMed ID: 24983591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.
    Breier A; Berg PH; Thakore JH; Naber D; Gattaz WF; Cavazzoni P; Walker DJ; Roychowdhury SM; Kane JM
    Am J Psychiatry; 2005 Oct; 162(10):1879-87. PubMed ID: 16199834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP; Spina E; Murray S; Yang R
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone.
    Rossi A; Vita A; Tiradritti P; Romeo F
    Int Clin Psychopharmacol; 2008 Jul; 23(4):216-22. PubMed ID: 18545060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
    Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
    Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trial.
    Calandre EP; Morillas-Arques P; Rodriguez-Lopez CM; Rico-Villademoros F; Hidalgo J
    Pharmacopsychiatry; 2007 Mar; 40(2):68-71. PubMed ID: 17447176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.